Cash from Operations (TTM) Chart

Historical Cash from Operations (TTM) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 1.368B
March 31, 2026 1.206B
December 31, 2025 1.178B
September 30, 2025 1.088B
June 30, 2025 905.81M
March 31, 2025 968.38M
December 31, 2024 929.00M
September 30, 2024 916.83M
June 30, 2024 969.18M
March 31, 2024 921.18M
December 31, 2023 906.51M
September 30, 2023 829.65M
June 30, 2023 746.22M
March 31, 2023 611.76M
December 31, 2022 542.55M
September 30, 2022 576.87M
June 30, 2022 575.08M
March 31, 2022 743.18M
December 31, 2021 752.90M
September 30, 2021 764.52M
June 30, 2021 770.43M
March 31, 2021 744.61M
December 31, 2020 648.06M
September 30, 2020 584.54M
June 30, 2020 523.69M
Date Value
March 31, 2020 452.65M
December 31, 2019 459.16M
September 30, 2019 439.39M
June 30, 2019 417.84M
March 31, 2019 399.56M
December 31, 2018 400.08M
September 30, 2018 385.56M
June 30, 2018 385.54M
March 31, 2018 376.90M
December 31, 2017 373.28M
September 30, 2017 352.27M
June 30, 2017 341.90M
March 31, 2017 342.62M
December 31, 2016 334.52M
September 30, 2016 308.30M
June 30, 2016 284.93M
March 31, 2016 254.18M
December 31, 2015 216.36M
September 30, 2015 169.77M
June 30, 2015 186.09M
March 31, 2015 187.68M
December 31, 2014 235.85M
September 30, 2014 274.81M
June 30, 2014 261.27M
March 31, 2014 258.83M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (TTM) Range, Past 5 Years

View Cash from Operations (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (TTM) Benchmarks

View Cash from Operations (TTM) Benchmarks
Start Trial
Neogen Corp. 83.20M
QuidelOrtho Corp. -57.20M
Aspira Women's Health, Inc. -4.562M
VolitionRX Ltd. -18.84M
Lucid Diagnostics, Inc. -46.87M